Literature DB >> 30959062

Fine particulate matter exposure during pregnancy and infancy and incident asthma.

Chau-Ren Jung1, Wei-Ting Chen2, Yu-Hsin Tang3, Bing-Fang Hwang4.   

Abstract

BACKGROUND: Lung development is a multistage process from conception to the postnatal period, disruption of which by air pollutants can trigger later respiratory morbidity.
OBJECTIVE: We sought to evaluate the effects of weekly average fine particulate matter (particulate matter with an aerodynamic diameter less than 2.5 μm [PM2.5]) exposure during pregnancy and infancy on asthma and identify vulnerable times to help elucidate possible mechanisms of the effects of PM2.5 on asthma symptoms.
METHODS: A birth cohort study including 184,604 children born during 2004-2011 in Taichung City was retrieved from the Taiwan Maternal and Child Health Database and followed until 2014. A daily satellite-based hybrid model was applied to estimate PM2.5 exposure for each subject. A Cox proportional hazard model combined with a distributed lag nonlinear model was used to evaluate the associations of asthma with PM2.5 exposure during pregnancy and infancy.
RESULTS: The birth cohort contained 34,336 asthmatic patients, and the mean age of children given a diagnosis of asthma was 3.39 ± 1.78 years. Increased exposure to PM2.5 during gestational weeks 6 to 22 and 9 to 46 weeks after birth were significantly associated with an increased incidence of asthma. The exposure-response relationship indicated that the hazard ratio (HR) of asthma increased steeply at PM2.5 exposure of greater than 93 μg/m3 during pregnancy. Additionally, the HRs remained significant with postnatal exposure to PM2.5 between 26 and 72 μg/m3 (range, 1.01-1.07 μg/m3), followed by a sharp increase in HRs at PM2.5 exposure of greater than 73 μg/m3.
CONCLUSION: Both prenatal and postnatal exposures to PM2.5 were associated with later development of asthma. The vulnerable time windows might be within early gestation and midgestation and infancy.
Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; air pollution; birth cohort; particulate matter with an aerodynamic diameter less than 2.5 μm; postnatal; prenatal; vulnerable time windows

Mesh:

Substances:

Year:  2019        PMID: 30959062     DOI: 10.1016/j.jaci.2019.03.024

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

1.  Prenatal particulate air pollution and newborn telomere length: Effect modification by maternal antioxidant intakes and infant sex.

Authors:  Alison G Lee; Whitney Cowell; Srimathi Kannan; Harish B Ganguri; Farida Nentin; Ander Wilson; Brent A Coull; Robert O Wright; Andrea Baccarelli; Valentina Bollati; Rosalind J Wright
Journal:  Environ Res       Date:  2020-05-21       Impact factor: 6.498

2.  Association between prenatal metal exposure and adverse respiratory symptoms in childhood.

Authors:  Nia McRae; Chris Gennings; Nadya Rivera Rivera; Marcela Tamayo-Ortiz; Ivan Pantic; Chitra Amarasiriwardena; Lourdes Schnaas; Rosalind Wright; Martha M Tellez-Rojo; Robert O Wright; Maria José Rosa
Journal:  Environ Res       Date:  2021-11-27       Impact factor: 6.498

3.  Association of General Anesthesia and Neuraxial Anesthesia in Caesarean Section with Maternal Postpartum Depression: A Retrospective Nationwide Population-Based Cohort Study.

Authors:  Kuo-Hsun Hung; Shao-Lun Tsao; Shun-Fa Yang; Bo-Yuan Wang; Jing-Yang Huang; Wen-Tyng Li; Liang-Tsai Yeh; Cheng-Hung Lin; Yin-Yang Chen; Chao-Bin Yeh
Journal:  J Pers Med       Date:  2022-06-14

4.  Comparison of childhood asthma incidence in 3 neighbouring cities in southwestern Ontario: a 25-year longitudinal cohort study.

Authors:  Dhenuka Radhakrishnan; Sarah E Bota; April Price; Alexandra Ouédraogo; Murad Husein; Kristin K Clemens; Salimah Z Shariff
Journal:  CMAJ Open       Date:  2021-05-04

5.  Maternal exposure to PM2.5 during pregnancy and asthma risk in early childhood: consideration of phases of fetal lung development.

Authors:  Marnie F Hazlehurst; Kecia N Carroll; Christine T Loftus; Adam A Szpiro; Paul E Moore; Joel D Kaufman; Kipruto Kirwa; Kaja Z LeWinn; Nicole R Bush; Sheela Sathyanarayana; Frances A Tylavsky; Emily S Barrett; Ruby H N Nguyen; Catherine J Karr
Journal:  Environ Epidemiol       Date:  2021-04

6.  Prenatal and early life exposure to particulate matter, environmental tobacco smoke and respiratory symptoms in Mexican children.

Authors:  Nadya Y Rivera Rivera; Marcela Tamayo-Ortiz; Adriana Mercado García; Allan C Just; Itai Kloog; Martha Maria Téllez-Rojo; Robert O Wright; Rosalind J Wright; Maria José Rosa
Journal:  Environ Res       Date:  2020-10-22       Impact factor: 6.498

Review 7.  The Role and Potential Pathogenic Mechanism of Particulate Matter in Childhood Asthma: A Review and Perspective.

Authors:  Xuchen Xu; Jianing Zhang; Xin Yang; Yuanyuan Zhang; Zhimin Chen
Journal:  J Immunol Res       Date:  2020-01-17       Impact factor: 4.818

8.  Does sex matter? Association of fetal sex and parental age with pregnancy outcomes in Taiwan: a cohort study.

Authors:  Tsung Yu; Ta-Sheng Chen; Fu-Wen Liang; Pao-Lin Kuo
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-08       Impact factor: 3.007

9.  Outdoor Air Pollution and New-Onset Airway Disease. An Official American Thoracic Society Workshop Report.

Authors:  George D Thurston; John R Balmes; Erika Garcia; Frank D Gilliland; Mary B Rice; Tamara Schikowski; Laura S Van Winkle; Isabella Annesi-Maesano; Esteban G Burchard; Christopher Carlsten; Jack R Harkema; Haneen Khreis; Steven R Kleeberger; Urmila P Kodavanti; Stephanie J London; Rob McConnell; Dave B Peden; Kent E Pinkerton; Joan Reibman; Carl W White
Journal:  Ann Am Thorac Soc       Date:  2020-04

10.  A randomised clinical trial to evaluate the safety, fit, comfort of a novel N95 mask in children.

Authors:  Daniel Yam Thiam Goh; Meng Wai Mun; Wei Liang Jerome Lee; Oon Hoe Teoh; Dimple D Rajgor
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.